Levodopa withdrawal syndrome identical to neuroleptic malignant syndrome
Open Access
- 1 January 1986
- journal article
- case report
- Published by Oxford University Press (OUP)
- Vol. 62 (723) , 59-60
- https://doi.org/10.1136/pgmj.62.723.59
Abstract
Summary: A 60 year old woman with idiopathic Parkinson's disease had been prescribed thioridazine for schizophrenia. Five months after this was stopped, Sinemet also considered of dubious therapeutic value, was withdrawn. One week later she developed features of the neuroleptic malignant syndrome (NMS) accompanied by myoglobinuric renal failure. Post-mortem examination confirmed Lewy body degeneration in the substantia nigra. It is proposed that NMS may be caused by levodopa withdrawal in Parkinson's disease, and that it is withdrawal of dopaminergic drive that causes the syndrome.Keywords
This publication has 6 references indexed in Scilit:
- Fatal hyperpyrexia after withdrawal of levodopaNeurology, 1984
- [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)].1982
- Neuroleptic Malignant syndrome caused by dopamine‐depleting drugs in a patient with Huntington diseaseNeurology, 1981
- Neuroleptic Malignant Syndrome-like State Following a Withdrawal of Antiparkinsonian DrugsJournal of Nervous & Mental Disease, 1981
- Neuroleptic malignant syndromeNeurology, 1981
- The hypothalamus in parkinson diseaseAnnals of Neurology, 1978